173 related articles for article (PubMed ID: 37158877)
1. Characterization of oral bacterial and fungal microbiome in recovered COVID-19 patients.
Wei N; Zhu G; Zhao T; Wang Y; Lou H; Li H; Yang Z; Zhang Z; Wang Q; Han M; Lin Z; Li S
BMC Microbiol; 2023 May; 23(1):123. PubMed ID: 37158877
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
[TBL] [Abstract][Full Text] [Related]
3. Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients.
Hu X; Wang H; Yu B; Yu J; Lu H; Sun J; Sun Y; Zou Y; Luo H; Zeng Z; Liu S; Jiang Y; Wu Z; Ren Z
Adv Sci (Weinh); 2023 Jul; 10(19):e2205058. PubMed ID: 37119437
[TBL] [Abstract][Full Text] [Related]
4. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analysis reveals increased abundance and diversity of opportunistic fungal pathogens in nasopharyngeal tract of COVID-19 patients.
Hoque MN; Rahman MS; Sarkar MMH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Hossain MA; Khan MS; Islam T
PLoS One; 2023; 18(1):e0278134. PubMed ID: 36656835
[TBL] [Abstract][Full Text] [Related]
6. Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections.
Zhou Y; Lu S; Wei X; Hu Y; Li H; Wang J; Lin Y; Li M; Wang M; Ma J; Zhu Z; Yang S; Ying B; Zhang W; Chen B; Li W
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671391
[TBL] [Abstract][Full Text] [Related]
7. Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.
Rizzello F; Viciani E; Gionchetti P; Filippone E; Imbesi V; Melotti L; Dussias NK; Salice M; Santacroce B; Padella A; Velichevskaya A; Marcante A; Castagnetti A
Front Cell Infect Microbiol; 2024; 14():1352202. PubMed ID: 38510960
[TBL] [Abstract][Full Text] [Related]
8. Oral dysbiosis and its linkage with SARS-CoV-2 infection.
Gupta A; Bhanushali S; Sanap A; Shekatkar M; Kharat A; Raut C; Bhonde R; Shouche Y; Kheur S; Sharma A
Microbiol Res; 2022 Aug; 261():127055. PubMed ID: 35597076
[TBL] [Abstract][Full Text] [Related]
9. Determinants and Interactions of Oral Bacterial and Fungal Microbiota in Healthy Chinese Adults.
Cheung MK; Chan JYK; Wong MCS; Wong PY; Lei P; Cai L; Lan L; Ho WCS; Yeung ACM; Chan PKS; Chen Z
Microbiol Spectr; 2022 Feb; 10(1):e0241021. PubMed ID: 35107355
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 alters human microbiomes: a meta-analysis.
Reuben RC; Beugnon R; Jurburg SD
Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients.
Gao M; Wang H; Luo H; Sun Y; Wang L; Ding S; Ren H; Gang J; Rao B; Liu S; Wang X; Gao X; Li M; Zou Y; Liu C; Yuan C; Sun J; Cui G; Ren Z
Adv Sci (Weinh); 2021 Oct; 8(20):e2102785. PubMed ID: 34423593
[TBL] [Abstract][Full Text] [Related]
12. Gut bacteria after recovery from COVID-19: a pilot study.
Polo PG; Çolak-Al B; Sentürk H; Rafiqi AM
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8599-8611. PubMed ID: 36459041
[TBL] [Abstract][Full Text] [Related]
13. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
[TBL] [Abstract][Full Text] [Related]
14. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
[TBL] [Abstract][Full Text] [Related]
15. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiome Alterations in COVID-19.
Zuo T; Wu X; Wen W; Lan P
Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):679-688. PubMed ID: 34560321
[TBL] [Abstract][Full Text] [Related]
17. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
[TBL] [Abstract][Full Text] [Related]
18. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity.
Maeda Y; Motooka D; Kawasaki T; Oki H; Noda Y; Adachi Y; Niitsu T; Okamoto S; Tanaka K; Fukushima K; Amiya S; Hara R; Oguro-Igashira E; Matsuki T; Hirata H; Takeda Y; Kida H; Kumanogoh A; Nakamura S; Takeda K
BMC Infect Dis; 2022 Jun; 22(1):572. PubMed ID: 35751044
[TBL] [Abstract][Full Text] [Related]
20. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
